Swiss media reports of defective Sonova cochlear implants

Sonova, which is based in Switzerland, is having problems with some of its cochlear implants, according to Swiss media NZZ am Sonntag, which reports that several patients must undergo surgery to have faulty implants removed.

Photo: Arnd Wiegmann/Reuters/Ritzau Scanpix

Swiss Sonova is having issues with defective cochlear implants, writes the domestic newspaper NZZ am Sonntag. According the Swiss media, implants will have to be surgically removed from several patients.

The news wasn't received well on Monday morning, as evident on the stock exchange in Zürich. Sonova stock decreased in value by 2 percent to CHF 383 (USD 419) after the news broke.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

In a world of options, Genmab's CEO chose partnerships

In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.

Further reading

Related articles

Latest news

See all jobs